ProMUS-NET:人工智能在微超声上检测出比泌尿科医生更多的前列腺癌
本研究开发了深度学习模型ProMUS-NET,用于在微超声(MUS)图像上自动分割国际泌尿病理学会分级组(GG)≥2的临床显著前列腺癌,并在五折交叉验证中评估性能。模型在匹配子队列中与六位专家泌尿科医生比较,实现了受试者工作特征曲线下面积0.92,病灶级灵敏度73%对58%,患者级灵敏度77%对66%。
要点
- ProMUS-NET在MUS上定位GG≥2前列腺癌的AUC达0.92。
- 模型病灶级灵敏度73%,高于六位专家的58%。
- 模型患者级灵敏度77%,高于专家的66%。
核心结论
- AI模型在MUS上识别前列腺癌病灶具有高灵敏度和特异度,病灶级和患者级灵敏度均高于专家泌尿科医生。
研究设计与样本
- 单机构前瞻性收集接受MRI-超声融合引导活检患者的MUS图像,训练no-new U-Net模型ProMUS-NET,采用五折交叉验证,并与六位专家泌尿科医生在匹配子队列中比较。
主要发现
- AI模型AUC为0.92,病灶级灵敏度73%对58%,患者级灵敏度77%对66%。
- AI对外周带病灶的病灶级灵敏度为86.2%。
关键数值与推荐
- 以活检病理和MRI信息交叉参照标注MUS图像上GG≥2临床显著癌的位置。
- 患者接受14针系统活检并对可疑MRI病灶额外靶向采样。
临床怎么用
- AI辅助MUS前列腺癌检测有望改善泌尿科医生的活检诊断。
局限性
- 需进一步改善边缘重叠、减少假阳性并进行外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To improve sensitivity and inter-reader consistency of prostate cancer localisation on micro-ultrasonography (MUS) by developing a deep learning model for automatic cancer segmentation, and to compare model performance with that of expert urologists. PATIENTS AND METHODS: We performed an institutional review board-approved prospective collection of MUS images from patients undergoing magnetic resonance imaging (MRI)-ultrasonography fusion guided biopsy at a single institution. Patients underwent 14-core systematic biopsy and additional targeted sampling of suspicious MRI lesions. Biopsy pathology and MRI information were cross-referenced to annotate the locations of International Society of Urological Pathology Grade Group (GG) ≥2 clinically significant cancer on MUS images. We trained a no-new U-Net model - the Prostate Micro-Ultrasound Network (ProMUS-NET) - to localise GG ≥2 cancer on these image stacks in a fivefold cross-validation. Performance was compared vs that of six expert urologists in a matched sub-cohort. RESULTS: The artificial intelligence (AI) model achieved an area under the receiver-operating characteristic curve of 0.92 and detected more cancers than urologists (lesion-level sensitivity 73% vs 58%; patient-level sensitivity 77% vs 66%). AI lesion-level sensitivity for peripheral zone lesions was 86.2%. CONCLUSIONS: Our AI model identified prostate cancer lesions on MUS with high sensitivity and specificity. Further work is ongoing to improve margin overlap, to reduce false positives, and to perform external validation. AI-assisted prostate cancer detection on MUS has great potential to improve biopsy diagnosis by urologists.
引用
- Zhou SR, Zhang L, Choi MH, et al. ProMUS-NET: Artificial intelligence detects more prostate cancer than urologists on micro-ultrasonography. BJU Int. 2025. PMID: 40859774. doi:10.1111/bju.16892
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。